Changzhou Zhongying Science & Technology Balance Sheet Health
Financial Health criteria checks 6/6
Changzhou Zhongying Science & Technology has a total shareholder equity of CN¥1.0B and total debt of CN¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CN¥1.1B and CN¥70.3M respectively. Changzhou Zhongying Science & Technology's EBIT is CN¥23.2M making its interest coverage ratio -1.8. It has cash and short-term investments of CN¥490.2M.
Key information
0%
Debt to equity ratio
CN¥0
Debt
| Interest coverage ratio | -1.8x |
| Cash | CN¥490.17m |
| Equity | CN¥1.01b |
| Total liabilities | CN¥70.30m |
| Total assets | CN¥1.08b |
Recent financial health updates
No updates
Recent updates
Changzhou Zhongying Science & Technology's (SZSE:300936) Anemic Earnings Might Be Worse Than You Think
Nov 04
Returns On Capital Signal Tricky Times Ahead For Changzhou Zhongying Science & Technology (SZSE:300936)
Oct 22Market Might Still Lack Some Conviction On Changzhou Zhongying Science & Technology Co., Ltd (SZSE:300936) Even After 27% Share Price Boost
Sep 30Changzhou Zhongying Science & Technology Co., Ltd (SZSE:300936) Held Back By Insufficient Growth Even After Shares Climb 28%
Jun 29Changzhou Zhongying Science & Technology (SZSE:300936) May Have Issues Allocating Its Capital
Jun 26Changzhou Zhongying Science & Technology (SZSE:300936) Shareholders Should Be Cautious Despite Solid Earnings
May 01Financial Position Analysis
Short Term Liabilities: 300936's short term assets (CN¥716.4M) exceed its short term liabilities (CN¥46.5M).
Long Term Liabilities: 300936's short term assets (CN¥716.4M) exceed its long term liabilities (CN¥23.8M).
Debt to Equity History and Analysis
Debt Level: 300936 is debt free.
Reducing Debt: 300936 has no debt compared to 5 years ago when its debt to equity ratio was 1.2%.
Debt Coverage: 300936 has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: 300936 has no debt, therefore coverage of interest payments is not a concern.